New monthly weight-loss jab shows promise in mid-stage trial
NCT ID NCT06973720
First seen Jan 24, 2026 · Last updated May 15, 2026 · Updated 17 times
Summary
This study tests a new medicine called MET097, given as a weekly shot for 12 weeks and then monthly, to see if it helps people with obesity or overweight lose weight safely. About 268 adults who do not have type 2 diabetes will take part. The main goal is to measure weight change after 28 weeks compared to a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CenExel iResearch, LLC
Decatur, Georgia, 30030, United States
-
CenExel iResearch, LLC
Savannah, Georgia, 31405, United States
-
ForCare Clinical Research
Tampa, Florida, 33613, United States
-
Hassman Research Institute
Marlton, New Jersey, 08053, United States
-
Research Centers of America
Hollywood, Florida, 33024, United States
Conditions
Explore the condition pages connected to this study.